Over 700,000 Americans are living with a brain tumor today. (1)
Nearly one-third (29.7 percent) of brain and central nervous system (CNS) tumors are malignant.
Unfortunately, there haven’t been any significant advancements to treat cancers for 40 years.
Even for top researchers, obstacles to progress have kept them from successful innovations. NeuVisium was designed to bring together leading researchers, doctors and cancer centers to put patient’s health and wellness before profits and remove these barriers, turning research ideas into applicable results. When a breakthrough treatment is found and more lives are being saved, the profits will follow.
Instead of only researching from Laboratory to Bedside, we’re pioneering a new method, Bedside to Bedside.
Visit our What We Do page to learn more!
1.Porter KR, McCarthy BJ, Freels S,Kim Y, Davis FG. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro-Oncology 12(6):520-527, 2010.
NeuVisium Foundation (NVF) is a 501c(3) non profit organization founded in 2017.
NeuVisium Discovery Commons (NVDC) was initiated to fast-track the development of treatments for diseases like brain tumors and leukemias. The concept has been in use at the University of Washington, Seattle to advance open source software development for over 20 years, and was further developed by a grant from the Ewing Marion Kauffman Foundation (Kansas City) to help expand its use.
Kuldip K. Ahluwalia refined NVDC over the past 7 years to survive two episodes of MDS/AML leukemia and two bone marrow transplants. The key concept behind NVDC is a keen collaboration amongst physicians and commercial partners to focus on helping the patient survive rather than maintaining commercial interests. If adopted, this methodology has the potential to save patient lives with a keen focus on patients rather than commercial interests.
Glioblastoma is an aggressive malignant brain tumor with poor prognosis. Glioblastoma is incurable and very little progress has been made to augment the survival rate of patients with glioblastoma over the past 40 years.
There is an urgent need to accelerate medical therapies for glioblastoma.
Neurosurgeons from institutions like Mayo Clinic, University of Louisville, Loma Linda University have expressed interest in joining in a collaborative effort to improve patient outcomes for brain tumors such as glioblastoma by sharing the knowledge learned from one patient and applying it to the next.
The healthcare system in the US seems entrenched and resistant to change. But, we’re already getting support from key influencers around the country in the healthcare field and government.
Our goal is to recruit five top medical institutions to join our Glioma Discovery Commons, and use our Bedside to Bedside system to share innovations that will save lives.
To do that, we will create a series of targeted campaigns designed to inspire and motivate patients, their families, their physicians, their institutions, and lawmakers to find ways to cure brain cancer.
After demonstrating the impact our system has, we will apply it to other challenging diseases that lack innovative cures.
But, we need your help to fund our campaigns and save lives.
NeuVisium Foundation is a nonprofit with a mission. That mission does NOT include funding lavish lifestyles for our executives and board members.
All of your generous donations will go towards funding our campaign to create a patient-focused research community that produces cures for brain cancer In a Patient’s Lifetime.
The campaign includes creating a variety of print and video content to educate and inspire the medical community, politicians, and especially patients and their families.
Your contribution is not only helping patients and their families, it is also reshaping the landscape of healthcare.
NeuVisium Foundation a 501 © (3) non profit
Fiscal Sponsor – Partnerships for Change
